The Hill | February 2, 2023
Read the PublicationThe 118th Congress has clearly signaled its commitment to addressing the growing availability of illicitly manufactured fentanyl in the United States. Already, the House Energy and Commerce Health Subcommittee held a roundtable and a hearing on the topic.
Related Initiatives
Related Projects
Access to Evidence-Based Treatment for Substance Use Disorder